Karen Afenjar

Articles by Karen Afenjar

23 Clinical Outcomes in Patients With HR+/HER2− Early Breast Cancer By Prior Systemic Treatment: A Subgroup Analysis of the NATALEE Trial

ByNicholas McAndrew,Stephen Chia,Fabio Puglisi,Aditya Bardia, MD, MPH, FASCO,Yann Izarzugaza,Christian Schem, MD,Binghe Xu,Fanny Le Du,Priyanka Sharma, MD,Karen Afenjar,Murat Akdere,Juan Pablo Zarate,Yogesh Chattar,Peter A. Fasching

June 23rd 2025

Latest Updated Articles

23 Clinical Outcomes in Patients With HR+/HER2− Early Breast Cancer By Prior Systemic Treatment: A Subgroup Analysis of the NATALEE Trial
June 23rd 2025

Trending on CancerNetwork

Tambiciclib Combo Shows Activity in Relapsed/Refractory Post-Venetoclax AML

BOT+BAL Yields Long-Term Survival in Patients With Refractory MSS mCRC

MASLD Raises Liver and Other Cancer Risks, Supporting Selective HCC Surveillance

Training, Invasiveness, and Workload Behind Falling Prostate Brachytherapy Use

Young Adults With Lung Cancer Often Fall Outside Screening Guidelines